EXOZYMES INC.
For the period ended Dec 31, 2024. Filed Mar 31, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 31, 2025
EXOZ$4.04-5.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
a. Documents Filed as Part of this Report
The following consolidated financial statements of eXoZymes Inc. are filed as part of this Annual Report on Form 10-K:
| Page | |
| CONSOLIDATED FINANCIAL STATEMENTS INDEX | |
|---|---|
| Report of Independent Registered Public Accounting Firm | F-1 |
| Audited Consolidated Financial Statements | |
| Consolidated Balance Sheets –December 31, 2024 and 2023 | F-2 |
| Consolidated Statements of Operations – Years Ended December 31, 2024 and 2023 | F-3 |
| Consolidated Statements of Changes in Stockholder’s Equity – Years Ended December 31, 2024 and 2023 | F-4 |
| Consolidated Statements of Cash Flows – Years Ended December 31, 2024 and 2023 | F-5 |
| Notes to Consolidated Financial Statements | F-6 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.